P53/MDM2 overexpression in metastatic endometrial cancer: correlation with clinicopathological features and patient outcome (Q80727434)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17671841%20AND%20SRC:MED&resulttype=core&format=json

3 January 2020

title

P53/MDM2 overexpression in metastatic endometrial cancer: correlation with clinicopathological features and patient outcome (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17671841%20AND%20SRC:MED&resulttype=core&format=json

3 January 2020

1 reference

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17671841%20AND%20SRC:MED&resulttype=core&format=json

3 January 2020

Tomasz Rechberger

7

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17671841%20AND%20SRC:MED&resulttype=core&format=json

3 January 2020

author name string

Ryszard Jeczen

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17671841%20AND%20SRC:MED&resulttype=core&format=json

3 January 2020

Danuta Skomra

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17671841%20AND%20SRC:MED&resulttype=core&format=json

3 January 2020

Regine Schneider-Stock

4

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17671841%20AND%20SRC:MED&resulttype=core&format=json

3 January 2020

Wiktor Szewczuk

5

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17671841%20AND%20SRC:MED&resulttype=core&format=json

3 January 2020

Albert Roessner

6

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17671841%20AND%20SRC:MED&resulttype=core&format=json

3 January 2020

Andrzej Semczuk

8

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17671841%20AND%20SRC:MED&resulttype=core&format=json

3 January 2020

publication date

2 August 2007

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17671841%20AND%20SRC:MED&resulttype=core&format=json

Clinical & Experimental Metastasis

3 January 2020

published in

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17671841%20AND%20SRC:MED&resulttype=core&format=json

3 January 2020

volume

24

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17671841%20AND%20SRC:MED&resulttype=core&format=json

3 January 2020

issue

7

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17671841%20AND%20SRC:MED&resulttype=core&format=json

3 January 2020

page(s)

503-511

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17671841%20AND%20SRC:MED&resulttype=core&format=json

Regulation of p53 localization

3 January 2020

cites work

1 reference

12 December 2020

Correlations between p21 expression and clinicopathological findings, p53 gene and protein alterations, and survival in patients with endometrial carcinoma

1 reference

12 December 2020

Preoperative evaluation and staging of endometrial cancer

1 reference

12 December 2020

Signaling to p53: breaking the MDM2-p53 circuit

1 reference

12 December 2020

Clinicopathological characteristics of p53 overexpression in endometrial cancers

1 reference

12 December 2020

Interpretation of p53 immunoreactivity in endometrial carcinoma: establishing a clinically relevant cut-off level

1 reference

12 December 2020

1 reference

12 December 2020

Current molecular aspects of the carcinogenesis of the uterine endometrium

1 reference

12 December 2020

Prognostic significance of angiogenesis and Ki-67, p53, and p21 expression: a population-based endometrial carcinoma study

1 reference

12 December 2020

Allelic loss at TP53 is not related to p53 protein overexpression in primary human endometrial carcinomas.

1 reference

12 December 2020

Regulation of the p53 protein by the MDM2 oncoprotein--thirty-eighth G.H.A. Clowes Memorial Award Lecture

1 reference

12 December 2020

Old and new perspectives in the pharmacological treatment of advanced or recurrent endometrial cancer: Hormonal therapy, chemotherapy and molecularly targeted therapies

1 reference

12 December 2020

p53 expression as a prognostic indicator of 5-year survival in endometrial cancer

1 reference

12 December 2020

TP53 overexpression in recurrent endometrial carcinoma.

1 reference

12 December 2020

MDM2 and p53 protein expression in the histologic subtypes of endometrial carcinoma

1 reference

12 December 2020

Live or let die: the cell's response to p53

1 reference

12 December 2020

Activation and activities of the p53 tumour suppressor protein

1 reference

12 December 2020

Prognostic aspects on endometrial hyperplasia and neoplasia

1 reference

12 December 2020

The MDM2-p53 interaction.

1 reference

12 December 2020

Overexpression of p53 protein is an independent prognostic indicator in human endometrial carcinoma

1 reference

12 December 2020

p14ARF silencing by promoter hypermethylation mediates abnormal intracellular localization of MDM2.

1 reference

12 December 2020

Prognostic significance of Bcl-2, p53 overexpression, and lymph node metastasis in surgically staged endometrial carcinoma

1 reference

12 December 2020

Inability of immunohistochemistry to predict clinical outcomes of endometrial cancer patients.

1 reference

12 December 2020

TP53 alterations in relation to the cell cycle-associated proteins p21, cyclin D1, CDK4, RB, MDM2, and EGFR in cancers of the uterine corpus

1 reference

12 December 2020

Discriminating functional and non-functional p53 in human tumours by p53 and MDM2 immunohistochemistry

1 reference

12 December 2020

Endometrial carcinoma: immunohistochemically detected proliferation index is a prognosticator of long-term outcome

1 reference

12 December 2020

The immunohistochemical profile of the primary and metastatic carcinoma of the clitoris: a case report

1 reference

12 December 2020

Two pathogenetic types of endometrial carcinoma

1 reference

12 December 2020

P53 overexpression predicts endometrial carcinoma recurrence better than HER-2/neu overexpression

1 reference

12 December 2020

Concerted regulation of wild-type p53 nuclear accumulation and activation by S100B and calcium-dependent protein kinase C.

1 reference

12 December 2020

Inactivation of tumor suppressor p53 by mot-2, a hsp70 family member.

1 reference

12 December 2020

A leucine-rich nuclear export signal in the p53 tetramerization domain: regulation of subcellular localization and p53 activity by NES masking

1 reference

12 December 2020

Distinctive p53 and mdm2 immunohistochemical expression profiles suggest different pathogenetic pathways in poorly differentiated endometrial carcinoma.

1 reference

12 December 2020

Prognostic significance of the infiltrative pattern invasion in endometrioid adenocarcinoma of the endometrium

1 reference

12 December 2020

Relationship between p53 pathway and estrogen receptor status in endometrioid-type endometrial cancer

1 reference

12 December 2020

Comparison of macroscopic appearance and estrogen receptor-alpha regulators after gene alteration in human endometrial cancer

1 reference

12 December 2020

Molecular genetic pathways in various types of endometrial carcinoma: from a phenotypical to a molecular-based classification

1 reference

12 December 2020

Endometrial carcinoma with pleural metastasis: A case report.

1 reference

12 December 2020

Bcl-2 inhibits p53 nuclear import following DNA damage

1 reference

12 December 2020

Surfing the p53 network

1 reference

12 December 2020

Angiogenesis, p53, and bcl-2 expression as prognostic indicators in endometrial cancer: comparison with traditional clinicopathologic variables

1 reference

12 December 2020

Cell cycle regulatory functions of the human oncoprotein MDM2.

1 reference

12 December 2020